James G. Kahn, MD, MPH

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
James G. Kahn, MD, MPH

Professor in Residence, Department of Epidemiology and Biostatistics, School of Medicine, UCSF

jgkahn@ucsf.edu

Phone: (415) 476-6642
Box 0936, UCSF
San Francisco, CA 94143-0936

View on UCSF Profiles

Cancer Center Membership

Associate Member » Cancer, Immunity, and Microenvironment

Selected Publications

  1. Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan 1; 176(1):65-73.
    View on PubMed
  2. Jain V, Chang W, Byonanebye DM, Owaraganise A, Twinomuhwezi E, Amanyire G, Black D, Marseille E, Kamya MR, Havlir DV, Kahn JG. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda. PLoS One. 2015; 10(12):e0143433.
    View on PubMed
  3. Curl PK, Kahn JG, Ordovas KG, Elicker BM, Naeger DM. Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening. AJR Am J Roentgenol. 2015 Aug; 205(2):344-7.
    View on PubMed
  4. Kahn JG, Hofmann P. Research ethics and health care reform. Science. 2015 Jun 19; 348(6241):1325-6.
    View on PubMed
  5. Verguet S, Kahn JG, Marseille E, Jiwani A, Kern E, Walson JL. Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya? Glob Health Action. 2015; 8:27695.
    View on PubMed
  6. Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG. Correction: Cost-Effectiveness Of Treatment Strategies for BRAF-Mutated Metastatic Melanoma. PLoS One. 2015; 10(4):e0126988.
    View on PubMed
  7. Chen IT, Aung T, Thant HN, Sudhinaraset M, Kahn JG. Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar. Malar J. 2015; 14(1):55.
    View on PubMed
  8. Juillard C, Smith R, Anaya N, Garcia A, Kahn JG, Dicker RA. Saving lives and saving money: Hospital-based violence intervention is cost-effective. J Trauma Acute Care Surg. 2015 Feb; 78(2):252-8.
    View on PubMed
  9. Downing J, El Ayadi A, Miller S, Butrick E, Mkumba G, Magwali T, Kaseba-Sata C, Kahn JG. Cost-effectiveness of the non-pneumatic anti-shock garment (NASG): evidence from a cluster randomized controlled trial in Zambia and Zimbabwe. BMC Health Serv Res. 2015; 15(1):37.
    View on PubMed
  10. Mirzazadeh A, Malekinejad M, Kahn JG. Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research. J Clin Epidemiol. 2015 Mar; 68(3):317-23.
    View on PubMed
  11. Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015 Feb 1; 93(2):118-24.
    View on PubMed
  12. Jiwani A, Himmelstein D, Woolhandler S, Kahn JG. Billing and insurance-related administrative costs in United States' health care: synthesis of micro-costing evidence. BMC Health Serv Res. 2014; 14:556.
    View on PubMed
  13. Zygourakis CC, Kahn JG. Cost-effectiveness research in neurosurgery. Neurosurg Clin N Am. 2015 Apr; 26(2):189-96, viii.
    View on PubMed
  14. Zygourakis CC, Oh T, Sun MZ, Barani I, Kahn JG, Parsa AT. Surgery is cost-effective treatment for young patients with vestibular schwannomas: decision tree modeling of surgery, radiation, and observation. Neurosurg Focus. 2014 Nov; 37(5):E8.
    View on PubMed
  15. Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG. Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma. PLoS One. 2014; 9(9):e107255.
    View on PubMed
  16. Marseille E, Kahn JG. Avahan and the cost-effectiveness of "prevention as prevention". Lancet Glob Health. 2014 Sep; 2(9):e493-4.
    View on PubMed
  17. Weile LK, Kahn JG, Marseille E, Jensen DM, Damm P, Lohse N. Global cost-effectiveness of GDM screening and management: Current knowledge and future needs. Best Pract Res Clin Obstet Gynaecol. 2015 Feb; 29(2):206-24.
    View on PubMed
  18. Lima VD, Thirumurthy H, Kahn JG, Saavedra J, Cárceres CF, Whiteside A. Modeling scenarios for the end of AIDS. Clin Infect Dis. 2014 Jul; 59 Suppl 1:S16-20.
    View on PubMed
  19. Marseille E, Jiwani A, Raut A, Verguet S, Walson J, Kahn JG. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries. BMJ Open. 2014; 4(6):e003987.
    View on PubMed
  20. Jiwani A, Matheson A, Kahn JG, Raut A, Verguet S, Marseille E, Walson J. Integrated disease prevention campaigns: assessing country opportunity for implementation via an index approach. BMJ Open. 2014; 4(3):e004308.
    View on PubMed

Go to UCSF Profiles, powered by CTSI